Ozempic is a medication many people know for Type 2 diabetes care and weight management. Beyond these uses, some people are asking whether it could offer another benefit.
Early research suggests Ozempic might help reduce alcohol cravings, and scientists are exploring whether this and similar medications could one day support people living with alcohol use disorder (AUD). It is not approved for this use, and more study is needed.
Let’s take a closer look at how Ozempic works and what current research says about its potential role in addiction care.
What Is Alcohol Use Disorder?
Alcohol use disorder (AUD) is a medical condition where a person drinks more than planned or finds it hard to stop, even when it causes problems at home, school, work, or with health. Signs include strong urges to drink, loss of control, and needing more alcohol to feel the same effects.
There are FDA-approved treatments, including naltrexone, acamprosate, and disulfiram. These are most effective when combined with care from a clinician, education, and support.
How Ozempic Works in the Brain
Ozempic (semaglutide) is a GLP-1 receptor agonist used for several medical purposes. These medications help manage blood sugar and reduce appetite. Some people taking GLP-1 drugs report that it felt easier to drink less. Research suggests these medicines affect the brain’s reward system, which also influences alcohol cravings.
In animal studies, semaglutide reduced alcohol intake. In a small human study, adults with AUD who received the medication drank about 30 percent less than those who received a placebo, and they reported fewer cravings during lab tasks.
Real World Data Is Encouraging
A large review of medical records from more than 1.3 million people also found a link: those prescribed semaglutide or tirzepatide had fewer emergency visits for alcohol-related problems than those not on these medications. This kind of data does not prove cause, but it points to a connection worth further study.
These early findings have led experts to call for more clinical trials to test safety and effectiveness.
How Ozempic Compares to Other Treatments
Right now, three medications are approved for AUD:
• Naltrexone (ReVia, Vivitrol, Depade)
• Acamprosate (Campral)
• Disulfiram (Antabuse)
These medicines work best alongside treatment and support. While they do not “cure” AUD, they can reduce cravings and create space to build recovery.
Ozempic is not approved for AUD, but early studies suggest it may reduce cravings and alcohol use. More clinical trials are needed before GLP-1 drugs can be considered safe and effective for this purpose.
These potential effects are different from how current medicines work. For example, naltrexone blocks rewarding effects of alcohol, acamprosate helps with withdrawal-related symptoms, and disulfiram causes unpleasant effects if alcohol is consumed.
If future studies support it, Ozempic might offer added benefits for some people, such as help with weight and blood sugar concerns that can co-occur with AUD.
Ozempic is a once-weekly injection. Most approved AUD medications are taken daily by mouth, except for injectable naltrexone. For now, clinicians will continue to rely on current medication-assisted treatment options.
GLP-1 medications can have side effects like nausea, digestive upset, fatigue, or headaches. They can also be costly or hard to obtain, especially when used off-label for alcohol cravings rather than diabetes care.
Should Ozempic Be Part of the Future of Addiction Treatment?
Some studies suggest Ozempic may support heart health, weight loss, and possibly certain mood symptoms. More research is needed to understand these effects fully in different populations.
The hope is that medicines like Ozempic could fit within a whole-person recovery plan that includes counseling, peer support, and long-term wellness strategies.
Ozempic and other GLP-1 medications show promise as future options for AUD. Until more evidence is available, it is best to stick with proven, evidence-based care and talk with a clinician about the safest next steps.
Help is available for anyone ready to change their relationship with alcohol. If you are struggling, reach out for clinical guidance. There are ways to reduce cravings, manage withdrawal safely, and build a plan that supports your long-term recovery.
About the Author
In Scott Huseby’s previous career, he led one of the most respected litigation support firms in the United States. Yet beyond his professional success, Scott discovered a deeper purpose after experiencing the healing power of recovery firsthand.
That calling led him to Costa Rica, where he became the owner of Costa Rica Recovery – an immersive residential recovery center in San José. Since then, Scott has opened additional treatment centers and become the owner of Cornerstone Recovery in Santa Ana, California (United States). Now he uses his leadership and lived experience to walk alongside others on their recovery journey, offering the same hope and healing that changed his life.
To learn more about Scott and Costa Rica Recovery, call 1 (866) 804-1793 or visit www.costaricarecovery.com
Copyright © 2025 California Business Journal. All Rights Reserved.
For California Business Journal Disclaimers, go to /terms-conditions/.
